greeksoup/ stock research
Stock research / United States / BNTX / Planned sales

BioNTech SE planned insider sales

In the last twelve months insiders at BioNTech SE filed 6 Form 144 notices of planned sales, 4.0 million shares worth $413.0 million at the time of filing, from 3 sellers. The latest, filed 3 September 2026: Medine GmbH (officer, 10% stockholder), 858,209 shares worth $89.1 million, planned for around 3 September 2026 through Berenberg Capital Markets LLC.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
3 September 2026Medine GmbHOfficer, 10% Stockholder858,209$89.1 million3 September 2026None on Form 4 yetBerenberg Capital Markets LLCStock Option ExerciseForm 144
12 May 2026Medine GmbHOfficer, 10% Stockholder858,209$80.4 million13 May 2026No matching Form 4 saleBerenberg Capital Markets LLCStock Option ExerciseForm 144
11 March 2026Poetting SierkOfficer150,000$12.6 million11 March 202650,000 shares from 22 April 2026Berenberg Capital Markets LLCPrivate Transaction; Stock Option ExerciseForm 144
12 February 2026Medine GmbHOfficer, 10% Stockholder858,209$93.9 million12 February 2026No matching Form 4 saleBerenberg Capital Markets LLCStock Option ExerciseForm 144
28 November 2025Tureci OzlemOfficer123,331$12.7 million28 November 2025No matching Form 4 saleBerenberg Capital Markets LLCStock Option ExerciseForm 144
13 November 2025Medine GmbHOfficer, 10% Stockholder1,114,130$124.4 million13 November 2025No matching Form 4 saleBerenberg Capital Markets LLCStock Option ExerciseForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?